Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01MUV
|
||||
| Former ID |
DNC007716
|
||||
| Drug Name |
1-benzhydryl-4-tert-butylpiperidin-4-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528781] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H29NO
|
||||
| Canonical SMILES |
CC(C)(C)C1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)O
|
||||
| InChI |
1S/C22H29NO/c1-21(2,3)22(24)14-16-23(17-15-22)20(18-10-6-4-7-11-18)19-12-8-5-9-13-19/h4-13,20,24H,14-17H2,1-3H3
|
||||
| InChIKey |
CSHMHUZYEYOBPL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [528781] | |
| Mu-type opioid receptor | Target Info | Inhibitor | [528781] | ||
| Nociceptin receptor | Target Info | Inhibitor | [528781] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.